Bioventus, LifeLink to co-develop next generation spine and trauma bone allograft

Biologics

Bioventus will co-develop a next generation bone allograft solution for spine and trauma surgery with Tampa, Fla.-based LifeLink Tissue Bank.

LifeLink Tissue Bank is part of the LifeLink Foundation, an independent, nonprofit organization dedicated to the recovery and transplantation of organs and tissue.

 

Bioventus is an orthobiologics company which offers products for bone healing, bone graft and knee osteoarthritis. Its Exogen Ultrasound Bone Healing System uses low intensity pulsed ultrasound to stimulate the body's natural healing process.

 

"The gift of tissue donation is invaluable and offers the opportunity to benefit so many patients in need," said Jean Davis, President and CEO of LifeLink Foundation. "Companies like Bioventus are helping to further enhance the immeasurable impact of tissue donations by investing in R&D to bring new solutions to the market and we are excited for our research teams to collaborate together on this development initiative."

 

More articles on biologics:

Johnson & Johnson, Trinity College Dublin collaborate on new global 3D bioprinting laboratory — 6 insights

First patient dosed with non-opioid therapy for OA pain in Centrexion Therapeutics' Phase 3 clinical trial: 4 insights

Bone Therapeutics completes recruitment for spinal fusion study: 4 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers